Statins as Either Immunomodulators or Anti-Cancer Drugs: Functional Activities on Tumor Stromal Cells and Natural Killer Cells

Author(s): Alessandro Poggi, Alessandra Musso, Silvia Boero, Paolo Canevali, Maria Raffaella Zocchi

Journal Name: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Formerly Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents

Volume 9 , Issue 1 , 2010

Become EABM
Become Reviewer
Call for Editor


It has been extensively shown that statins, inhibitors of 3-hydroxyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase can effectively be used in the treatment of hypercholesterolemia. Indeed, coronary morbidity and mortality related to atherosclerotic plaque dependent cardiovascular diseases have been greatly reduced by their employment. Recently, it has been shown that statins can affect cell growth and survival of solid tumours and leukaemic cells. Indeed, it has been proposed their employment in multiple myeloma treatment in association with thalidomide or its derivatives. On the other hand, statins have strong anti-inflammatory and immunomodulatory effects and thus they may have a role in the regulation of anti-tumour immunity. Indeed, there are several evidences that inflammation may promote oncogenesis and, on the other hand, inflammation may participate in cancer rejection. Herein, we analyze the effects that statins can exert on cancer cells, stromal cells in tumor microenvironment and anti-tumor cytolytic activity of human natural killer cells.

Keywords: Statins, natural killer cells, tumor microenvironment, mesenchymal stromal cells

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [82 - 92]
Pages: 11
DOI: 10.2174/187152310790711719
Price: $65

Article Metrics

PDF: 29